1. What are the business and financing risks associated with the acquisition of Genentech? Is this a good time to do the deal?
2. Do you believe the bond issuance will have an impact on Roche's bond rating?
3. What are the prevailing spreads for non-Roche bonds? Do you think these spreads are similar to investor's required yield for the Roche bonds?
4. What is your specific recommendation for the coupon rate for the Roche 5-year, 10-year, and 30-year U.S. dollar bonds?
5. What would your coupon rate recommendation be for the 7-year bond in euro?

Answer rating: 100% (QA)

1 Business and financing risks associated with the acquisition of Genentech Integration challenges M... View the full answer